Open AccessEffect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction
Author(s) -
Leandro Rocha Messias,
Aryanne Guimarães Ferreira,
Sandra Marina Ribeiro de Miranda,
José Antônio Caldas Teixeira,
Jader Cunha de Azevedo,
Ana Messias,
Elisabeth Maróstica,
Cláudio Tinoco Mesquita
Publication year - 2016
Publication title -
arquivos brasileiros de cardiologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 53
eISSN - 1678-4170
pISSN - 0066-782X
DOI - 10.5935/abc.20160046
Subject(s) - medicine , nebivolol , ejection fraction , cardiology , heart rate , heart failure , blood pressure , hemodynamics
More than 50% of the patients with heart failure have normal ejection fraction (HFNEF). Iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy and cardiopulmonary exercise test (CPET) are prognostic markers in HFNEF. Nebivolol is a beta-blocker with vasodilating properties.